Search Results - "Masamitsu, Mikami"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2
  3. 3

    Refeeding syndrome in a small‐for‐dates micro‐preemie receiving early parenteral nutrition by Mizumoto, Hiroshi, Mikami, Masamitsu, Oda, Hirotsugu, Hata, Daisuke

    Published in Pediatrics international (01-10-2012)
    “…This report describes a small‐for‐date extremely low birth weight infant who manifested bradycardic events, respiratory failure, and hemolytic jaundice during…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Vaccine-strain herpes zoster found in the trigeminal nerve area in a healthy child: A case report by Iwasaki, Sayaka, Motokura, Kouji, Honda, Yoshitaka, Mikami, Masamitsu, Hata, Daisuke, Hata, Atsuko

    Published in Journal of clinical virology (01-12-2016)
    “…Abstract A previously healthy 2-year-old girl, vaccinated for varicella at 17 months, was admitted because of left-sided facial herpes zoster caused by…”
    Get full text
    Journal Article
  8. 8

    Impact of pretransplant minimal residual disease on the post-transplant outcome of pediatric acute lymphoblastic leukemia by Umeda, Katsutsugu, Hiramatsu, Hidefumi, Kawaguchi, Koji, Iwai, Atsushi, Mikami, Masamitsu, Nodomi, Seishiro, Saida, Satoshi, Heike, Toshio, Ohomori, Katsuyuki, Adachi, Souichi

    Published in Pediatric transplantation (01-08-2016)
    “…There are few reports on the clinical significance of MRD before HSCT in pediatric ALL. We retrospectively analyzed the clinical significance of FCM‐based…”
    Get full text
    Journal Article
  9. 9

    Impact of post‐transplant minimal residual disease on the clinical outcome of pediatric acute leukemia by Umeda, Katsutsugu, Iwai, Atsushi, Kawaguchi, Koji, Mikami, Masamitsu, Nodomi, Seishiro, Saida, Satoshi, Hiramatsu, Hidefumi, Heike, Toshio, Ohmori, Katsuyuki, Adachi, Souichi

    Published in Pediatric transplantation (01-06-2017)
    “…This retrospective study examined the clinical significance of FCM‐MRD in 36 patients with ALL and 29 patients with AML after their first allogeneic HSCT…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    ET-06 Suppression of glioblastoma through novel drug based on “Gene Switch Technology” by Yamamoto, Etsuko, Arakawa, Yoshiki, Mineharu, Youhei, Mikami, Masamitsu, Matsui, Yasuzumi, Sugiyama, Hiroshi, Miyamoto, Susumu, Adachi, Souichi, Kamikubo, Yasuhiko

    Published in Neuro-oncology advances (28-11-2020)
    “…Glioblastoma (GBM) is the most common and aggressive malignancy primarily affecting adults. Despite intensive multimodal therapies, the prognosis of GBM is…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18